newsletter subscription
email
SATELLITE SYMPOSIA
Satellite Symposium 1: Navigating Atopic Dermatitis in Infants
VIATRIS - Platinum Partner
Thursday, 29 May 2025
16:00 - 17:00, Auditorium
16:00 - 16:05
Welcome & objective setting - Prof. Thomas Luger, Austria
16:05 - 16:15
Why Early Treatment Matters: Protecting Infant Skin from the Start - Dra. Ángela Hernández Martín, Spain
16:15 - 16:30
Topical Therapies in Infants: Striking the Balance Between Efficacy & Safety - Prof. Thomas Luger, Austria
16:30 - 16:45
Beyond Topicals: Systemic Approaches & Combination Strategies in infants - Prof. Beatrix Volc-Platzer, Austria
16:45 - 16:50
Key takeaways - Prof. Thomas Luger, Austria
16:50 - 17:00
Q&A session - All Speakers
Symposium is restricted only to prescribing HCPs.
Satellite Symposium 2 - Hands Up for A Brighter Future in Epidermolysis Bullosa
CHIESI - Diamond Partner
Friday, 30 May 2025
12:55 - 13:55, Auditorium
Chair: Dr Anna Bruckner (University of Colorado School of Medicine, Department of Dermatology, Aurora, Colorado, USA)
12:55 - 13:15
Advancing care and treatments in a changing landscape - Dr Anna Bruckner (University of Colorado School of Medicine, Aurora, Colorado, USA)
13:15 - 13:25
Practical considerations to ensure success: Clinical experience from Greece - Prof Dimitra Kiritsi (Aristotle University of Thessaloniki, Thessaloniki, Greece)
13:25 - 13:40
The importance of teamwork: Clinical experience from Birmingham, UK - Dr Malobi Ogboli (Birmingham Children’s Hospital, Birmingham, England, UK) and Ms Gemma Harrison (Birmingham Children’s Hospital, Birmingham, England, UK)
13:40 - 13:55
Q&A and Closing Remarks
Aims: The symposium aims to provide an overview of the current landscape in Epidermolysis Bullosa (EB) management, including unmet needs and current treatments. The panel will share real-world clinical experiences from Europe and the US, highlighting best practices and notable case presentations. The symposium will focus on paediatric data and practical considerations for successful EB treatment including both physician and nurse perspectives.
Symposium is restricted only to prescribing HCPs.
Lunch boxes will be distributed after the symposium to attending delegates.
Satellite Symposium 3 - A breakthrough in the management of Dystrophic Epidermolysis Bullosa – the impact of the first targeted corrective therapy
Krystal - Silver Partner
Friday, 30 May 2025
16:20 - 17:20, Auditorium
Chair: Christine Bodemer
16:20 - 16:30
Welcome and Introduction - Christine Bodemer
16:30 - 16:50
The development of the first approved targeted corrective therapy – from clinical trials to regulatory approval in EU and US - Cristina Has
16:50 - 17:10
From clinical trials to clinical practice – the impact of B-VEC in patients with DEB - Agnes Schwieger-Briel
17:10 - 17:20
Questions and Discussion - Moderated by the chair
Symposium is restricted only to prescribing HCPs.
ESPD OFFICE
domain
Address for official postal correspondence:
ESPD Office
c/o C-IN
5. kvetna 65, Prague Congress Centre
140 21 Prague 4
Czech Republic
Registered at:
1 Place de l'Hôpital
670 91 Strasbourg CEDEX
France
mail_outline
Office email address
office@espd.info
Copyright © 2022 European Society for Pediatric Dermatology
Powered by APPTIDE | Created by C-IN | Privacy Policy